1. Home
  2. MNMD vs RERE Comparison

MNMD vs RERE Comparison

Compare MNMD & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • RERE
  • Stock Information
  • Founded
  • MNMD 2019
  • RERE 2011
  • Country
  • MNMD United States
  • RERE China
  • Employees
  • MNMD N/A
  • RERE N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • RERE Other Specialty Stores
  • Sector
  • MNMD Health Care
  • RERE Consumer Discretionary
  • Exchange
  • MNMD Nasdaq
  • RERE Nasdaq
  • Market Cap
  • MNMD 672.1M
  • RERE 678.4M
  • IPO Year
  • MNMD N/A
  • RERE 2021
  • Fundamental
  • Price
  • MNMD $7.63
  • RERE $2.92
  • Analyst Decision
  • MNMD Strong Buy
  • RERE
  • Analyst Count
  • MNMD 10
  • RERE 0
  • Target Price
  • MNMD $28.11
  • RERE N/A
  • AVG Volume (30 Days)
  • MNMD 3.1M
  • RERE 654.1K
  • Earning Date
  • MNMD 03-06-2025
  • RERE 03-11-2025
  • Dividend Yield
  • MNMD N/A
  • RERE N/A
  • EPS Growth
  • MNMD N/A
  • RERE N/A
  • EPS
  • MNMD N/A
  • RERE N/A
  • Revenue
  • MNMD N/A
  • RERE $2,188,701,829.00
  • Revenue This Year
  • MNMD N/A
  • RERE $28.08
  • Revenue Next Year
  • MNMD N/A
  • RERE $25.05
  • P/E Ratio
  • MNMD N/A
  • RERE N/A
  • Revenue Growth
  • MNMD N/A
  • RERE 27.16
  • 52 Week Low
  • MNMD $4.66
  • RERE $1.11
  • 52 Week High
  • MNMD $12.22
  • RERE $3.70
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 47.18
  • RERE 51.16
  • Support Level
  • MNMD $7.81
  • RERE $2.92
  • Resistance Level
  • MNMD $10.44
  • RERE $3.01
  • Average True Range (ATR)
  • MNMD 1.01
  • RERE 0.16
  • MACD
  • MNMD -0.06
  • RERE -0.01
  • Stochastic Oscillator
  • MNMD 29.07
  • RERE 52.21

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.

About RERE ATRenew Inc.

ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.

Share on Social Networks: